SCHEMBL4482984

SCHEMBL4482984

O=C(NCc1ccccc1)c1ccc(=O)n(Cc2c(Cl)cccc2Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.60
BRD2 P25440 1/20 0.60
BRD3 Q15059 1/20 0.60
BRDT Q58F21 1/20 0.60
ALDH1A1 P00352 7/20 0.56
MAPT P10636 3/20 0.53
GAA P10253 2/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
KLKB1 P03952 3/20 0.53
KDM4E B2RXH2 3/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
MAPK8 P45983 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.48
NPSR1 Q6W5P4 2/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4476510 0.86 P2RX7 (0.59) BRD4ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL4470067 0.85 GAA (0.59) MAPTGAASMN1; SMN2CYP3A4CYP2C9
SCHEMBL4481461 0.82 ALDH1A1 (0.56) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL18669063 0.76 SYK (0.58) MAPTRAB9ASMN1; SMN2L3MBTL1NPSR1
SCHEMBL2760209 0.75 BRD4 (0.55) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL2736608 0.73 ALDH1A1 (0.59) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL12745890 0.73 BRD4 (0.63) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL1617368 0.72 BRD4 (0.70) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL5648574 0.72 LMNA (0.75) ALDH1A1MAPTGAARAB9ASMN1; SMN2
SCHEMBL13701754 0.72 BRD4 (0.73) BRD4BRD2BRD3BRDTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058964-A1 Substituted pyridinones PHARMACIA LLC 2004-03-25 US claimed
US-7629363-B2 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease PFIZER INC (US) 2009-12-08 US disclosed
US-7067540-B2 Substituted pyridinones PHARMACIA CORPORATION (US) 2006-06-27 US disclosed
US-20050176775-A1 Substituted pyridinones PHARMACIA CORPORATION 2005-08-11 US disclosed
US-20040058964-A1 Substituted pyridinones PHARMACIA LLC 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058964-A1 Substituted pyridinones MAPK1, MAPK6, MAPK7 BRD4 2724/4885BRD2 3307/4885BRD3 3060/4885
US-20050176775-A1 Substituted pyridinones MAPK1, MAPK6, MAP3K6 BRD4 2431/4885BRD2 2981/4885BRD3 2751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.